Results 21 to 30 of about 107 (107)
Медицинский совет, 2013 This literature review outlines the role of glutamatergic disturbances in the pathogenesis of cognitive disorders. There is data on the effectiveness of the glutamate NMDA-receptors antagonist - memantine - in patients with various dementias: Alzheimer's
I. S. Preobrazhenskaya
doaj +1 more source
Some aspects of medication and non-medication treatment of Alzheimer's disease
Медицинский совет, 2015 The article tells about a contemporary approach to the treatment of patients with Alzheimer's disease (AD). There are findings related to the effectiveness of the glutamate NMDA receptor antagonist memantine in AD, its effect on cognitive deficit ...
O. V. Kotova, E. S. Akarachkova
doaj +1 more source
Pathogenesis, diagnosis and treatment of Alzheimer's disease
Медицинский совет, 2015 The article is devoted to pathogenesis and diagnosis of Alzheimer's disease. The possibilities of treatment are discussed. Efficacy data for the basic symptomatic treatment of Alzheimer's disease, the potential and prospects of nootropic therapy are ...
A. A. Naumenko, I. S. Preobrazhenskaya
doaj +1 more source
Bioequivalence study drug containing memantine
Фармакокинетика и Фармакодинамика, 2013 At present, Russia has developed domestic analogue of Memantine Akatinol — Memaneyrin in the form of droplets which is pharmaceutically equivalent drug memantine Akatinol.
A. A. Karlitskaya +5 more
doaj
Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo UniversitetaВведение. Деменция на сегодняшний день занимает седьмое место среди ведущих причин смертности в мире. Ведущая форма деменции в мировой практике – болезнь Альцгеймера (БА), на долю которой приходится примерно 60-70% случаев. Каждый год происходит почти 10
А. А. Лакутин +3 more
doaj +1 more source
Cognitive disorders and therapy in patients with hypertension
Медицинский совет, 2014 Hypertension plays an important role in the development and progression of cognitive disorders. Numerous epidemiological studies show that uncontrolled hypertension is a separate proven, potent risk factor for cognitive disorders, including severe ...
N. V. Vakhnina
doaj +1 more source
Клинико-экономические аспекты терапии болезни Альцгеймера в России
Качественная клиническая практика, 2018 Экселон ТТС обладает необходимыми клинико-экономическими характеристиками для включения в государственные программы лечения деменции. Он превосходит по показателю минимизации затрат Реминил (галантамин) и Акатинол (мемантина гидрохлорид), включенные в ...
doaj
Alzheimer's disease and diabetes mellitus
Медицинский совет, 2015 Recently, healthcare specialists have put great emphasis on the relationship between Alzheimer's disease and diabetes. There are many common pathogenic mechanisms underlying both diseases: insulin resistance, hyperinsulinemia, chronic hyperglycemia ...
A. N. Bogolepova
doaj +1 more source
Accumulation of aggregated alpha-synuclein in neural tissue structures in neurodegenerative diseases
Acta Biomedica ScientificaA critical analysis of the literature on the structure and properties of alpha-synuclein under physiological and pathological conditions is presented, when the conformation of this protein changes, which contributes to its aggregation and changes in ...
V. N. Salkov, D. N. Voronkov
doaj +1 more source
Дисциркуляторная энцефалопатия и сосудистые когнитивные расстройства
Неврология, нейропсихиатрия, психосоматика, 2018 В книге изложены данные литературы и результаты исследований автора и его учеников, посвященные диагностике и дифференциальной диагностике, лечению и профилактике хронической цереброваскулярной патологии.
doaj